Breakthrough Device Designation granted to the AI Software for CTEPH

  • Home Blog Fda alert breakthrough device designation granted to the artificial intelligence software for cteph

Breakthrough Device Designation granted to the AI Software for CTEPH

Dec 05, 2018

FDA

FDA

Downloads

Article in PDF

Recent Articles
  1. FDA Approves ZURZUVAE for Postpartum Depression; Astellas Drug Acquired in $5.9B Deal Wins FDA Ap...
  2. Meeting the Unmet Need for Oral Mucositis
  3. Opdivo for carcinoma; Rucaparib receives designation; Sunovion buys; Insys marketed drug
  4. FDA is reviewing a dangerous way to treat Peanut Allergy
  5. Notizia
pharma-news-for-bayer-klotho-trethera
Notizia - Recent Pharma, Healthcare and Biotech Happenings

Nanoscope’s MCO-010 Begins FDA Rolling Submission for Retinitis Pigmentosa; Bayer’s KERENDIA Approved by FDA for Heart Failure With Preserved Ejection Fraction; Klotho Neurosciences’ KLTO-202 Receives FDA Orphan Drug Designation for ALS; Trethera’s TRE-515 Granted FDA Fast Track Designation for Metastatic Prostate Cancer; Adcentrx’s ADRX-0405 Awarded FDA Orphan Drug Designation for Gastric Cancer

pharma-news-for-merck-kalvista-mustang
Notizia - Recent Pharma, Healthcare and Biotech Happenings

Merck’s WINREVAIR Granted FDA Priority Review for Pulmonary Arterial Hypertension; KalVista’s EKTERLY Approved by FDA as First Oral On-Demand Therapy for Hereditary Angioedema; Fujifilm’s FF-10832 Receives FDA Orphan Drug Designation for Biliary Tract Cancer; Mustang Bio’s MB-101 Granted FDA Orphan Drug Designation for Glioblastoma and Astrocytomas; Denali’s Tividenofusp Alfa Accepted for FDA Priority Review for Hunter Syndrome

amniotic-membrane-market-regenerative-healthcare
Articles

How the Amniotic Membrane Market is Transforming Regenerative Healthcare Worldwide

AI Software
artificial intelligence
CTEPH
FDA
loader
loader